Shenzhen Microchip Biotechnology Co., Ltd

Short Form Report on Changes in Equity

Listed company name: Shenzhen Microchip Biotechnology Co., Ltd

Stock listing location: Shanghai Stock Exchange

Stock abbreviation: Chipscreen Biosciences

Stock Code: 688321

Information disclosure obligor 1: Residence and mailing address of Shenzhen Haide Ruida Enterprise Management Partnership (Limited Partnership): 11G, Building 1, Huangting Century, No. 3004, Yitian Road, Huanggang Community, Futian Street, Futian District, Shenzhen

Information Disclosure Obligor 2: Nanchang Haide Ruiyuan Enterprise Management Partnership (Limited Partnership)

Residence and mailing address: 4th Floor, No. 1, Long'an Avenue, New Economic Industrial Park, Anyi County, Nanchang City, Jiangxi Province

INFORMATION DISCLOSURE OBLIGOR 3: XIANPING LU

Residence and mailing address: Nanshan District, Shenzhen*****

Information disclosure obligor 4: Shenzhen Haiyuemen Biotechnology Development Co., Ltd

Residence and mailing address: Unit 20, Dongbin Road, Nanshan Street, Nanshan District, Shenzhen, 14C Information Disclosure Obligor 5: Shenzhen Haide Ruibo Investment Co., Ltd

Residence and mailing address: 21D, Building 7, Peninsula City-State Garden (Phase III), South of Wanghai Road, Dongjiaotou Community, Shekou Street, Nanshan District, Shenzhen

Information Disclosure Obligor 6: Shenzhen Haide Kangcheng Investment Partnership (Limited Partnership)

Residence and mailing address: 21D, Building 7, Peninsula City-State Garden (Phase III), South of Wanghai Road, Dongjiaotou Community, Shekou Street, Nanshan District, Shenzhen

Information Disclosure Obligor 7: Shenzhen Haide Xincheng Enterprise Management Partnership (Limited Partnership) domicile and mailing address: 21D, Building 7, Peninsula City-State Garden (Phase III), Dongjiaotouwanghai Road, Shekou Street, Nanshan District, Shenzhen

Nature of share change: The change in equity is caused by the termination of the concerted action relationship by some information disclosure obligors, and the shares of the company held by information disclosure obligor 1 and information disclosure obligor 2 are no longer combined with other information disclosure obligors, and this equity change does not involve a change in the number of shares held.

Date of signing: 17.01.2025

Disclosure Obligor Statement

1. The information disclosure obligor prepares this report in accordance with the Securities Law of the People's Republic of China (hereinafter referred to as the "Securities Law"), the Administrative Measures for the Acquisition of Listed Companies (hereinafter referred to as the "Acquisition Measures"), the Guidelines for the Content and Format of Information Disclosure of Companies Offering Securities to the Public No. 15 - Report on Changes in Equity (hereinafter referred to as the "Guidelines No. 15") and relevant laws, regulations and normative documents.

2. The Disclosure Obligor has obtained the necessary authorization and approval to sign this report, and its performance does not violate or conflict with any provision of the Disclosure Obligor's partnership agreement or internal rules.

3. In accordance with the provisions of the Securities Law, the Takeover Measures, and the Guidelines No. 15, this is the case

The report has fully disclosed the changes in the shares in which the information disclosure obligor has an interest in Shenzhen Chipscreen Biotechnology Co., Ltd. (hereinafter referred to as "Chipscreen Biotech" or the "listed company").

As of the date of this report, the information disclosure obligor has not increased or decreased its shares in Chipscreen Biosciences by any means other than the shareholding information disclosed in this report.

4. The change in equity is based on the information contained in this report. The information disclosure obligor has not entrusted or authorized any other person to provide information not included in this report and to make any explanation or explanation of this report.

5. The information disclosure obligor undertakes that there are no false records, misleading statements or material omissions in this report, and assumes individual and joint legal liability for its authenticity, accuracy and completeness.

directory

Section 1: Interpretation...... 5

Section 2: Introduction of Information Disclosure Obligors...... 7

Section 3 Purpose of Equity Change and Shareholding Plan ...... 17

Section 4 Methods of Changes in Equity ...... 18

Section 5 Trading of Listed Shares in the Preceding Six Months ...... 20

Section 6: Other Major Matters...... 21

Section 7: Statement of the Disclosure Obligor...... 22

Section 8: Documents for Reference...... 24

Schedule...... 25

Short Form Report on Changes in Equity...... 25

Section 1: Interpretation

In this report, unless the context otherwise requires, the following expressions shall have the following meanings:

Listed Company, Company, Chipscreen Biosciences refers to Shenzhen Chipscreen Biotechnology Co., Ltd

Information Disclosure Obligor 1, Shenzhen Hydray Enterprise Management Partnership (Limited Contract

finger

Partner)

Information disclosure obligor 2, Haiderui Nanchang Haide Ruiyuan Enterprise Management Partnership (limited contract

finger

Far Guy)

INFORMATION DISCLOSURE OBLIGOR 3 REFERS TO XIANPING LU

Information Disclosure Obligor 4. Haiyuemen refers to Shenzhen Haiyuemen Biotechnology Development Co., Ltd

Information Disclosure Obligor 5, Headray

Refers to Shenzhen Hyde Ruibo Investment Co., Ltd

wide

Information disclosure obligor 6, Haidekang

Refers to Shenzhen Haide Kangcheng Investment Partnership (Limited Partnership)

Yes

Information disclosure obligor 7, Haide Xin Shenzhen Haide Xincheng Enterprise Management Partnership (limited contract

finger

Partnership)

refers to Hydreda, Hydrek as of July 5, 2018

"Concerted Action Agreement", Concerted Action

Signing: Signed with XIANPING LU and other persons acting in concert

Dynamic Protocols

Concerted Action Agreement

MEANS TO MAINTAIN ONE WITH THE INFORMATION DISCLOSURE OBLIGOR 3 XIANPING LU

Other persons acting in concert refer to:

To the action relationship of Haiyuemen, Haide Ruibo, Haide Kangcheng,

Hyde Xincheng

Shenzhen Microchip Biotechnology Co., Ltd

Report on Changes in Equity, this report refers to:

Report of Change

Exchange means the Shanghai Stock Exchange

Yuan, 10,000 yuan refers to the Chinese yuan

Stocks refer to RMB ordinary shares

In this report on changes in equity, if the sum of the partial totals and the additions is directly added, it is at the end

There are discrepancies in the numbers, all of which are due to rounding.

Section 2: Introduction of Information Disclosure Obligors

1. Basic information of the person obligated to disclose information

(1) Information disclosure obligor 1

Name: Shenzhen Haide Ruida Enterprise Management Partnership (Limited Partnership)

No. 3004, Yitian Road, Huanggang Community, Futian Street, Futian District, Shenzhen

Registered address

Royal Century 1 Building 11G

Managing Partner Zhu Pai

The registered capital is 40,617,197 yuan

Unified Social Credit Code 9144030035941703X4

Type of business: Limited partnership

Main business scope: project consulting and enterprise management (excluding restricted projects)

Operating period: 2015-12-02 to 2028-1-31

Note: Shenzhen Headruida Enterprise Management Partnership (Limited Partnership) has yet to go through the corresponding market supervision and management department change registration for the business period, general partner and executive partner.

Information Disclosure Obligor 1 Main Persons in Charge:

Name Zhu Pai

Gender Male

Nationality Chinese

IC No. 440301************

Position: Managing Partner

Long-term residence: Nanshan District, Shenzhen, Guangdong Province****

Whether you have obtained the right of abode in another country or region No

(2) Information disclosure obligor 2

Name: Nanchang Haide Ruiyuan Enterprise Management Partnership (Limited Partnership)

1, Longan Avenue, New Economic Industrial Park, Anyi County, Nanchang City, Jiangxi Province

Registered address

No. 4th Floor

Managing Partner: Liu Fengchen

The registered capital is 40,617,197 yuan

Unified Social Credit Code 914403003594169770

Type of business: Limited partnership

The general business projects are: project consulting and enterprise management (not limited

Main business scope

( )

Operating period 2015-12-02 to 5000-01-01

Note: Nanchang Haide Ruiyuan Enterprise Management Partnership (Limited Partnership) has yet to go through the corresponding market supervision and management department change registration for the change of general partner and executive partner.

Information Disclosure Obligor 2 Main Persons in Charge:

Name Liu Fengchen

Gender Male

Nationality Chinese

IC No. 130105************

Position: Managing Partner

Long-term residence: Nanshan District, Shenzhen, Guangdong Province****

Whether you have obtained the right of abode in another country or region No

(3) Information disclosure obligor 3

NAME XIANPING LU

Gender Male

Nationality USA

Passport number 67*******

Long-term residence Nanshan District, Shenzhen****

Whether or not to obtain residency in other countries or regions of China

Position in the company Chairman and general manager of the company

(4) Information disclosure obligor 4

Name: Shenzhen Haiyuemen Biotechnology Development Co., Ltd

Unit 20, Urban Mountain Forest, Dongbin Road, Nanshan Street, Nanshan District, Shenzhen

Registered address

14C

Legal representative: Ning Zhiqiang

The registered capital is 10.0000 RMB

Unified Social Credit Code 91440300750470319N

Type of business: Limited liability company

Main business scope: Technology development of biological products (excluding restricted items)

Operating period 2003-05-27 to 2033-05-27

Information Disclosure Obligor 4 Main Persons in Charge:

Name Ning Zhiqiang

Gender Male

Nationality Chinese

IC No. 461611************

Position: Legal representative

Long-term residence: Nanshan District, Shenzhen, Guangdong Province****

Whether you have obtained the right of abode in another country or region No

(5) Information disclosure obligor 5

Name: Shenzhen Haide Ruibo Investment Co., Ltd

South side of Wanghai Road, Dongjiaotou Community, Shekou Street, Nanshan District, Shenzhen

Registered address

Peninsula City-State Gardens (Phase III) Building 7, 21D

Legal representative: Zhao Shumei

The registered capital is 3,482,061 RMB

Unified Social Credit Code 91440300680386786N

Type of business: Limited liability company

The general business projects are: investment in the establishment of industries (specific projects are separated.)

Main business scope

declaration); Biotechnology development (excluding restricted items)

Operating period: 2008-09-09 to 2028-09-09

Information Disclosure Obligor 5 Main Persons in Charge:

Name Zhao Shumei

Gender Female

Nationality Chinese

IC No. 510311************

Position: Legal representative

Long-term residence: Nanshan District, Shenzhen, Guangdong Province****

Whether you have obtained the right of abode in another country or region No

(6) Information disclosure obligor 6

Name: Shenzhen Haide Kangcheng Investment Partnership (Limited Partnership)

South side of Wanghai Road, Dongjiaotou Community, Shekou Street, Nanshan District, Shenzhen

Registered address

Peninsula City-State Gardens (Phase III) Building 7, 21D

Managing Partner Seagull

The registered capital is 44,215,200 RMB

Unified Social Credit Code 914403003265935478

Type of business: Limited partnership

The general business project is: equity investment in unlisted enterprises

Main business scope (except for items prohibited by laws, administrative regulations, and decisions of the State Council,

Restricted items must be licensed before they can be operated)

Operating period 2015-02-11 to 5000-01-01

Information Disclosure Obligor 6 Main Persons in Charge:

Name Seagull

Gender Female

Nationality Chinese

IC No. 230106************

Position: Managing Partner

Long-term residence: Nanshan District, Shenzhen, Guangdong Province****

Whether you have obtained the right of abode in another country or region No

(7) Information disclosure obligor 7

Name: Shenzhen Haide Xincheng Enterprise Management Partnership (Limited Partnership)

The peninsula city-state of Wanghai Road, Dongjiaotou, Shekou Street, Nanshan District, Shenzhen

Registered address

Garden (Phase III) Building 7, 21D

MANAGING PARTNER, XIANPING LU

The registered capital is 30,515,245 yuan

Unified Social Credit Code 91440300354461592F

Type of business: Limited partnership

Main business scope: project consulting and enterprise management

Operating period 2015-11-29 to 5000-01-01

Note: For the basic information of the main person in charge of the information disclosure obligor 7, please refer to the information disclosure obligation

Person 3.

2. The shares in which the information disclosure obligor has an interest in other listed companies at home or abroad reach or exceed 5% of the issued shares of the company

As of the date of this report, the information disclosure obligor does not have an interest in other listed companies in China or overseas that reaches or exceeds 5% of the issued shares of the company.

3. The relationship between the information disclosure obligors

(1) The signing and performance of the concerted action agreement

XIANPING LU IS THE GENERAL PARTNER AND EXECUTIVE PARTNER OF HEDR AND HEDG

GANGS, HAIDERUIDA, HAIDE RUIYUAN, XIANPING LU AND OTHER CONCERTED ACTORS

The Concerted Action Agreement was signed on 5 July 2018, pursuant to the Concerted Action Agreement

Relevant agreements, Hydreida, Hyde Ruiyuan, Xianping LU and other persons acting in concert agree that:

(1) THE PARTIES ACKNOWLEDGE THAT EACH PARTY EXISTED WITH XIANPING LU FROM 24 MONTHS PRIOR TO THE SIGNING OF THE AGREEMENT

concerted action relationships; The parties undertake to continue to maintain a consistent relationship of action within 36 months from the signing of the agreement to the date of listing of the Company on domestic and foreign stock exchanges; After 36 months from the date of listing on domestic and foreign stock exchanges, the concerted action relationship shall continue to exist unless either party notifies the other parties in writing to terminate the concerted action relationship, and the parties who have not terminated the concerted action relationship shall continue to act in concert.

(2) Each party undertakes that, from the date of signing this Agreement, it will be in the daily production and operation of the Company and its When he directly or indirectly exercises the right to make proposals, nominations, voting rights and other rights to the general meeting of shareholders and the board of directors in decision-making on major matters, all parties shall have the same opinion as XIANPING LU.

(3) The parties agree that the exercise of shareholder rights will be fully agreed upon in advance

The proposal shall be submitted to the Board of Directors and the General Meeting of Shareholders for consideration and shall be voted on by consensus. If there are still different opinions after full consultation, the parties agree that the opinions of XIANPING LU shall prevail.

(4) The parties undertake that Haiyuemen, Haide Ruibo, Haide Kangcheng, Haide Ruida, and Haide

Neither Ruiyuan nor Haide Xincheng will entrust the voting rights of all or part of the company's shares held by them to a third party other than XIANPING LU by entrustment, trust, etc. The aforesaid parties will not circumvent XIANPING by waiving the right to propose, nominate, vote and other rights

LU acts in unison.

(5) Each party undertakes that each party shall ensure that the directors nominated or appointed by it are reviewed by the board of directors of the company

When exercising the right to vote on the bill, the opinion shall be consistent with that of XIANPING LU.

(6) Each party expressly states that the relationship of action determined by this Agreement shall not be unilateral to either party

Revocation or Revocation. All the terms related to the concerted action relationship described in this Agreement are the true expression of the intention of the parties, and there is no fraud, coercion or other circumstances against the true will of the person, and the relevant provisions of the concerted action relationship described in this Agreement are irrevocable and irrevocable.

(7) If either party fails to comply with the provisions of this Agreement at the general meeting of shareholders and the board of directors of the company

The proposal or vote shall be deemed to be in breach of contract, and the proposal or vote shall be null and void ab initio.

(8) If either party violates the provisions of this Agreement, it shall not violate the laws, regulations and norms

Under the premise of sexual documents and articles of association, take effective measures to eliminate the impact of its breach of contract; If one party breaches the contract and causes actual losses to the non-breaching party, the breaching party shall bear the liability for breach of contract.

At the time of the signing of the concerted action agreement, Chipscreen Biosciences was still in the process of improving and improving the corporate governance structure and decision-making mechanism, and the establishment and effective operation of the concerted action relationship between all parties played a significant role in enhancing the stability of the company's control structure and ensuring the unity of business decision-making. Since the signing of the concert agreement, the parties have fully complied with the agreement on concerted action, and there has been no violation of the concerted action agreement.

(2) The circumstances of the dissolution of the concerted action relationship

HEDR AND HEDR WERE RELEASED ON JANUARY 17, 2025 WITH XIANPING LU AND OTHERS

The Concert Entities signed the Supplemental Agreement to the Concert Agreement to terminate the concert relationship between them and XIANPING LU.

Each information disclosure obligor confirms that there is no disagreement in the strategic direction, production and operation, management and personnel arrangements of Chipscreen Biosciences; There is no dispute or potential dispute between the information disclosure obligor and Chipscreen Biosciences and other shareholders, and there is no harm to the interests of Chipscreen Biosciences and its shareholders; After the dissolution of the concerted action relationship, Hydreda and Hydrek are far from reaching concerted action or other benefit arrangements with other shareholders of the Company or any third party, and there is no intention or further arrangement to seek control of the Company for the time being; In accordance with the provisions of relevant laws, regulations, normative documents and the articles of association of the company, and in accordance with their respective wishes, we will independently enjoy and exercise the rights of shareholders, fulfill the obligations of relevant shareholders, and continue to support the long-term and stable development of the company.

At the same time, Hyde Ruida and Hyde Ruiyuan confirmed that the termination of the concerted action relationship is not for the purpose of dispersing or evading the relevant commitments to reduce shareholdings, nor does it violate or indirectly exempt the commitments made by relevant shareholders at the time of the company's listing, and will strictly follow the relevant provisions of relevant laws, regulations and normative documents on shareholder shareholding and share changes, and standardize the performance of relevant commitments in good faith; At the same time, Hyde and Hyde Ray voluntarily undertake to act in concert on the date of termination

Within six months (i.e., from January 17, 2025 to July 16, 2025, hereinafter referred to as the "Lock

Periodically"), not to reduce its holdings of Chipscreen Biosciences in any form, nor to repurchase the shares held by Chipscreen Biosciences, and continue to comply with Article 11 of the Interim Measures for the Administration of Shareholding Reduction by Shareholders of Listed Companies (hereinafter referred to as the "Measures"), that is, in the last 20 trading days, if the closing price of the stock (backward compounding) on any day is lower than the stock issue price at the time of the initial public offering, it shall not reduce its shareholding through centralized bidding or block trading on the stock exchange. At present, the company's share price is still lower than the issue price of the shares at the time of the initial public offering, and Hydrida and Hyde Ruiyuan will continue to comply with this regulation until the expiration of the lock-up period

It will not reduce any of its shares in Chipscreen Biosciences until the statutory conditions are met.

(3) Before the above-mentioned concerted action relationship is dissolved, the control relationship chart of the above-mentioned information disclosure obligor over the company

(4) After the above-mentioned concerted action relationship is dissolved, the above-mentioned information disclosure obligor holds shares of the company

Section 3 Purpose of Equity Change and Shareholding Plan

1. The purpose of this change in equity

On January 17, 2025, the information disclosure obligors were Haidruida, Haide Ruiyuanhe

XIANPING LU issued a "Notification Letter on No Longer Constituting a Concerted Action Relationship", in which the parties confirmed that Hydreda, Hyde Ruiyuan, XIANPING LU and other parties acting in concert have signed the "Supplemental Agreement to the Concerted Action Agreement" to terminate the concerted action relationship between Hydreda, Hydley and XIANPING LU.

The change in equity is caused by the termination of the concerted action relationship by some information disclosure obligors, and does not involve a change in the number of shares.

2. The information disclosure obligor shall hold shares in the next 12 months

As of the date of this report, Hydreda and Hyde are not in the next 6 months

In the plan to reduce the shareholding of Chipscreen Biosciences, each information disclosure obligor will not rule out increasing or reducing its holdings of Chipscreen Biosciences shares in the next 12 months. If there is a change in relevant rights and interests in the future, the information disclosure obligor will perform the information disclosure obligation in a timely manner in strict accordance with the provisions of relevant laws and regulations.

Section 4: Methods of Changes in Equity and Interests

1. Basic information on changes in equity rights

THE INFORMATION DISCLOSURE OBLIGORS ARE HEADED, HEADLINE AND XIANPING LU IN 2025

On January 17, the Company issued a "Notification Letter on No Longer Constituting a Concerted Action Relationship", in which all parties confirmed the concerted action relationship between Headred, Hydray and XIANPING LU

On January 17, 2025, the controlling shareholder and actual controller of the company will remain XIANPING

LU。

This change in equity is caused by the dissolution of the concerted action relationship between some information disclosure obligors, and does not involve a change in the number of shares.

2. Before and after the change in equity, the information disclosure obligor holds the company's shares

Prior to this equity change, Haide Ruida, Haide Ruiyuan and XIANPING LU and Haiyuemen,

Haide Ruibo, Haide Kangcheng and Haide Xin became persons acting in concert, directly holding a total of 113,202,606 shares of the company, accounting for 27.76% of the company's existing total share capital.

Shareholding ratio

Serial No. Name of Shareholder Company Position Number of Shares Held (Shares)

（%）

1 Headrider / 11,753,849 2.88%

2 Heide Ruiyuan / 11,753,849 2.88%

XIANPING Chairman,

3 22,239,625 5.45%

General Manager of LU

4 Haiyuemen / 22,936,008 5.62%

5 Hydrebo / 19,817,445 4.86%

6 Hyde Conbridge / 15,285,290 3.75%

7 HIDE Xincheng / 9,416,540 2.31%

Total 113,202,606 27.76%

After this change in equity, the number and proportion of shares held by the information disclosure obligors remain unchanged, and the shares and proportions of the company held by XIANPING LU and other persons acting in concert will no longer be combined, and the proportion of voting rights held by XIANPING LU and other entities acting in concert will be reduced from 27.76% to 22.00% of the total voting rights of the company's shares, XIANPING LU He is still the controlling shareholder and actual controller of the company.

3. Restrictions on the rights of the shares of the listed company held by the information disclosure obligor

As of the date of signing this report, there is no restriction on the rights of the shares held by the information disclosure obligor, including but not limited to the pledge, seizure and freezing of the shares.

Section 5 Trading of Listed Shares within the Previous Six Months

In the six months prior to the date of signing this report, the information disclosure obligor has not bought or sold the company's shares.

Section 6: Other major matters

As of the date of signing this report, the information disclosure obligor has truthfully disclosed the relevant information of the change in equity in accordance with the relevant regulations, and there is no other material information that the information disclosure obligor should disclose but has not disclosed in accordance with the law and relevant regulations.

Section 7: Statement by the Disclosure Obligor

I (and the organization I represent) undertake that there are no false records, misleading statements or material omissions in this report, and I assume individual and joint legal responsibility for its authenticity, accuracy and completeness.

Disclosure Obligor 1:

Shenzhen Haide Ruida Enterprise Management Partnership (Limited Partnership) (seal)

Managing Partner (signed): Zhu Pai

Disclosure Obligor 2:

Nanchang Haide Ruiyuan Enterprise Management Partnership (Limited Partnership) (seal)

Managing Partner (signed): Liu Fengchen

INFORMATION DISCLOSURE OBLIGOR 3: XIANPING LU (Signed)

Information disclosure obligor 4: Shenzhen Haiyuemen Biotechnology Development Co., Ltd. (seal)

Legal representative (signed): Ning Zhiqiang

Information Disclosure Obligor 5: Shenzhen Haide Ruibo Investment Co., Ltd. (seal)

Legal representative (signed): Zhao Shumei

Information Disclosure Obligor 6: Shenzhen Haide Kangcheng Investment Partnership (Limited Partnership)

(stamped)

Managing Partner (Signed): Seagull

Information Disclosure Obligor 7: Shenzhen Haide Xincheng Enterprise Management Partnership (Limited Contract

Guy) (stamped)

(Signed): XIANPING LU

Date of signing: January 17, 2025

Section 8 Documents for reference

1. Documents for reference:

1. A copy of the business license/identity document of the information disclosure obligor;

2. A copy of the identity document of the main person in charge of the information disclosure obligor;

3. The text of this report signed by the information disclosure obligor;

4. Notification Letter on No Longer Constituting a Concerted Action Relationship.

Second, the place where the documents for reference are prepared:

This report and the above-mentioned documents are available for inspection by investors at the office of the Board of Directors of the Company.

schedule

Short Form Report on Changes in Equity

Basic information

Listed company Shenzhen Microchip Biotechnology stock listed company Shenzhen, Guangdong Province

Name of Copy Limited Location

Stock abbreviation: Chipscreen Biosciences stock code: 688321

Information Disclosure Shenzhen Haide Ruida Enterprise Information Disclosure

Volunteer: 1 Management Partnership (Limited Obligor 1: Shenzhen, Guangdong Province

Name Partnership) place of registration

Information disclosure Nanchang Haide Ruiyuan Enterprise Management Information Disclosure

Volunteer: 2 Partnership: (Limited Contractor: 2) Nanchang City, Jiangxi Province

Name of the partner) place of registration

Information Disclosure Information Disclosure

VOLUNTEER 3 XIANPING LU VOLUNTEER 3 SHENZHEN, GUANGDONG PROVINCE

Name Place of registration

Information disclosure Shenzhen Haiyuemen Biological Science and Technology Information Disclosure

Volunteer 4 Technology Development Co., Ltd. Obligor 4 Shenzhen City, Guangdong Province

Name Place of registration

Information Disclosure Shenzhen Hyde Rebo Investment has information disclosure

Volunteer: 5 Company Obligor 5: Shenzhen, Guangdong Province

Name Place of registration

Information Disclosure Shenzhen Haide Kangcheng Investment Information Disclosure

Obligation 6 Partnership (Limited Partnership) Obligor 6 Shenzhen City, Guangdong Province

Name Place of registration

Information Disclosure Shenzhen Haide Xincheng Enterprise Information Disclosure

Volunteer: 7 Management Partnership (Limited Obligor: 7) Shenzhen, Guangdong Province

Name Partnership) place of registration

Yes? None □

(This time the concerted action is lifted.)

After the relationship, Hydreda,

Increasing □ Decreasing □ Hyde Ray is far from being with

Ownership rights and interests remain unchanged ?? (WHETHER OR NOT THERE IS A CONSISTENT XIANPING LU CONSTITUTES ONE.)

The number of shares of the action relationship is dissolved, and the action relationship of the shares is caused by the person acting on the shares, but

VOLUME CHANGES QUANTITIES ARE NO LONGER COMBINED) XIANPING LU REMAINS AND ITS

He acted in concert with the main body of the sea

Yuemen, Haide Ruibo, Hai

Dekangcheng and Haide Xin Cheng

into a concerted action relationship)

Be? No □

(XIANPING LU IS MALE.)

The actual controller of the company, this time

After the change in equity, it is related to the sea

Information Disclosure Information Disclosure Yuemen, Haide Ruibo, Hai

The volunteer is the obligor, and the obligor is Dekangcheng and Haide Xincheng

no is it listed on the market yes □ no ?? whether to be listed to maintain a consistent action relationship,

Company 1 actually controls the company's shares in total

The proportion of major shareholders controlling the voting rights will be reduced

to 21.9950%.

DOES NOT AFFECT XIANPING

LU as the de facto control of the company

Human status)

Transfer of □ through a centralized trading □ agreement on a stock exchange

Changes in rights and interests Administrative transfer or change of state-owned shares □ indirect transfer □

Method (New shares issued by the listed company can be obtained□ Enforcement of the court's ruling □

Multiple choice) Inheritance □ Gift □

Other? (It is the dissolution of the concerted action relationship, and the number of shares is no longer combined.)

count)

Stock Type: RMB Ordinary Shares (A Shares)

Hedrida: Number of direct shares: 11,753,849 shares, shareholding ratio:

2.88%；

Haide Ruiyuan: Number of direct shares: 11,753,849 shares, shareholding ratio:

2.88%；

XIANPING LU: Number of direct shares: 22,239,625 shares, shareholding ratio

Examples of volunteers: 5.45%;

Haiyuemen: Number of direct shares: 22,936,008 shares, shareholding ratio:

equity of shares 5.62%;

The number of servings is as good as possible

Number of shares directly held: 19,817,445 shares, shareholding ratio:

4.86%;

Proportion of shares

Haide Kangcheng: Number of direct shares: 15,285,290 shares, shareholding ratio:

3.75%；

Haide Xincheng: Number of direct shares: 9,416,540 shares, shareholding ratio:

2.31%。

The information disclosure obligor holds shares of Chipscreen Biosciences in aggregate through a concerted action relationship

113,202,606 shares, total shareholding: 27.76%.

Stock Type: RMB Ordinary Shares (A Shares)

Hedrida: Number of direct shares: 11,753,849 shares, shareholding ratio:

2.88%；

Haide Ruiyuan: Number of direct shares: 11,753,849 shares, shareholding ratio:

2.88%；

XIANPING LU: Number of Direct Shares: 22,239,625 Shares, Shareholding Ratio

Examples of rights and interests: 5.45%;

After the change,

Information Disclosure Haiyuemen: Number of direct shares: 22,936,008 shares, shareholding ratio:

5.62% were volunteers;

Beneficial Hyde Rebo: Number of direct shares: 19,817,445 shares, shareholding ratio:

the number of shares 4.86%;

and the change ratio

Example: Number of direct shares: 15,285,290 shares, shareholding ratio:

3.75%；

Haide Xincheng: Number of direct shares: 9,416,540 shares, shareholding ratio:

2.31%。

The concerted action relationship between Hydrida, Hydra and XIANPING LU

Released on January 17, 2025, a single information disclosure obligor has a right and interest

There was no change in the shares.

Public Date: January 17, 2025

The company's ownership method: This change in equity is caused by the dissolution of the equity action relationship of some information disclosure obligors, and the shares of the company held by the changed LU and other persons acting in concert with XIANPING are no longer combined, and the time and party This change in equity does not involve a change in the number of shares, and the disclosure of individual information is meaningful

There is no change in the shares in which the employee has an interest.

Yes □ No □ Not applicable ?

Whether it has been charged (This change in equity is caused by the termination of the disclosing of the information disclosure relationship by some information disclosure obligors, and the shares of the company held by Hydreida, Hyde Ruiyuan, Xianping LU Gold Source and other persons acting in concert are no longer combined

The change in secondary equity does not involve a change in the number of shares held, so it does not involve related capital

Kim Contact)

Is the disclosure □ is it not? □??? Not applicable???

The Volunteers are (as of the date of this report, each information disclosure obligor in the next 12 years

whether it intends to increase its shareholding in the listed company within the next month. In the next 12 months, if there is a change in relevant rights and interests in the future, the information disclosure obligor will strictly continue to increase the information disclosure obligation in a timely manner in accordance with the provisions of relevant laws and regulations. ）

hold

Information Disclosure

The volunteers are there

Previously 6

month yes no in yes □ no ?

Level 2 market

Buy and sell that on

Municipal company shares

ticket

(There is no text on this page, it is the signature page of the "Report on Changes in Equity of Shenzhen Microchip Biotechnology Co., Ltd.")

Disclosure Obligor 1:

Shenzhen Haide Ruida Enterprise Management Partnership (Limited Partnership) (seal)

Managing Partner (signed): Zhu Pai

Disclosure Obligor 2:

Nanchang Haide Ruiyuan Enterprise Management Partnership (Limited Partnership) (seal)

Managing Partner (signed): Liu Fengchen

INFORMATION DISCLOSURE OBLIGOR 3: XIANPING LU (Signed)

Information disclosure obligor 4: Shenzhen Haiyuemen Biotechnology Development Co., Ltd. (seal)

Legal representative (signed): Ning Zhiqiang

Information Disclosure Obligor 5: Shenzhen Haide Ruibo Investment Co., Ltd. (seal)

Legal representative (signed): Zhao Shumei

Information Disclosure Obligor 6: Shenzhen Haide Kangcheng Investment Partnership (Limited Partnership)

(stamped)

Managing Partner (Signed): Seagull

Information Disclosure Obligor 7: Shenzhen Haide Xincheng Enterprise Management Partnership (Limited Contract

Guy) (stamped)

(Signed): XIANPING LU

Date of signing: January 17, 2025